ALLERGENIC EXTRACT NON POLLENS LIQUID

Država: Kanada

Jezik: engleski

Izvor: Health Canada

Aktivni sastojci:

NON POLLEN

Dostupno od:

ALK-ABELLO INC

ATC koda:

V01AA20

INN (International ime):

VARIOUS

Doziranje:

100000UNIT

Farmaceutski oblik:

LIQUID

Sastav:

NON POLLEN 100000UNIT

Administracija rute:

INTRADERMAL

Jedinice u paketu:

5/10/30/50ML

Tip recepta:

Schedule D

Područje terapije:

ALLERGENIC EXTRACTS

Proizvod sažetak:

Active ingredient group (AIG) number: 0109346002; AHFS:

Status autorizacije:

APPROVED

Datum autorizacije:

2005-02-02

Svojstava lijeka

_Product Monograph Master Template _
_Template Date: September 2020 _
_ALLERGENIC EXTRACTS _
_Page 1 of 16_
PRODUCT MONOGRAPH
INCLUDING PATIENT MEDICATION INFORMATION
ALLERGENIC EXTRACT POLLENS
ALLERGENIC EXTRACT NON POLLENS
Allergenic Extracts for Diagnostic Use Only
Liquid, Intradermal, Percutaneous
ALK-ABELLO INC
35 Channel Drive
Port Washington
New York
United States 11050
Distributed in Canada by:
ALK-Abelló Pharmaceuticals, Inc.
#35-151 Brunel Road
Mississauga, Ontario
Canada L4Z 2H6
Submission Control Number: 275814 Date of Revision: January 17, 2024
_ _
_Product Monograph Master Template _
_Template Date: September 2020 _
_ALLERGENIC EXTRACTS _
_Page 2 of 16_
TABLE OF CONTENTS
SECTIONS OR SUBSECTIONS THAT ARE NOT APPLICABLE AT THE TIME OF
AUTHORIZATION ARE NOT LISTED
.
TABLE OF CONTENTS
..............................................................................................................
2
PART I: HEALTH PROFESSIONAL INFORMATION
.....................................................................
4
1
INDICATIONS
..............................................................................................................
4
1.1
Pediatrics
..........................................................................................................
4
1.2
Geriatrics...........................................................................................................
4
2
CONTRAINDICATIONS
.................................................................................................
4
3
SERIOUS WARNINGS AND PRECAUTIONS BOX
............................................................ 4
4
DOSAGE AND
ADMINISTRATION.................................................................................
5
4.1
Dosing Considerations
.......................................................................................
5
4.2
Recommended Dose and Dosage
Adjustment..................................................... 5
4.3
Dilution
.................................................................................